Literature DB >> 28776085

60 years of metformin use: a glance at the past and a look to the future.

Sally M Marshall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28776085     DOI： 10.1007/s00125-017-4343-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  30 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  The pharmacogenetics of metformin.

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 3.  Metformin: clinical use in type 2 diabetes.

Authors:  Elizabeth Sanchez-Rangel; Silvio E Inzucchi
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

Review 4.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 5.  Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.

Authors:  Juan Pablo Domecq; Gabriela Prutsky; Aaron Leppin; M Bassam Sonbol; Osama Altayar; Chaitanya Undavalli; Zhen Wang; Tarig Elraiyah; Juan Pablo Brito; Karen F Mauck; Mohammed H Lababidi; Larry J Prokop; Noor Asi; Justin Wei; Salman Fidahussein; Victor M Montori; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2015-01-15       Impact factor: 5.958

Review 6.  Metformin and the gastrointestinal tract.

Authors:  Laura J McCreight; Clifford J Bailey; Ewan R Pearson
Journal:  Diabetologia       Date:  2016-01-16       Impact factor: 10.122

Review 7.  Metformin use in pregnancy: promises and uncertainties.

Authors:  Robert S Lindsay; Mary R Loeken
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

Review 8.  Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

Authors:  Ruth E Farmer; Deborah Ford; Harriet J Forbes; Nishi Chaturvedi; Richard Kaplan; Liam Smeeth; Krishnan Bhaskaran
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

9.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

10.  Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.

Authors:  Manuj Sharma; Irwin Nazareth; Irene Petersen
Journal:  BMJ Open       Date:  2016-01-13       Impact factor: 2.692
View more
  30 in total

1.  The bark giving diabetes therapy some bite: the SGLT inhibitors.

Authors:  Sally M Marshall
Journal:  Diabetologia       Date:  2018-10       Impact factor: 10.122

2.  Restoration of mRNA Expression of Solute Carrier Proteins in Liver of Diet-Induced Obese Mice by Metformin.

Authors:  Jiamei Le; Yi Fu; Qiuqin Han; Xindong Wei; Houlin Ji; Yifan Chen; Qiuying Wang; Peixian Pi; Jilei Li; Xinjie Lin; Xiaoying Zhang; Yong Zhang; Jianping Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

3.  Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease.

Authors:  Fang-Fang Cheng; Yan-Li Liu; Jang Du; Jun-Tang Lin
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

4.  Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway.

Authors:  Xiangyu Gao; Xiaona Qiao; Xiaoxia Xing; Jinya Huang; Jiali Qian; Yi Wang; Yawen Zhang; Xi Zhang; Miao Li; Jiefeng Cui; Yehong Yang
Journal:  Front Oncol       Date:  2020-08-19       Impact factor: 6.244

5.  Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery.

Authors:  Rakan I Nazer; Mohammed F Abalhassan; Khalid A Alburikan
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

Review 6.  Metformin and cardiorenal outcomes in diabetes: A reappraisal.

Authors:  John R Petrie; Peter R Rossing; Ian W Campbell
Journal:  Diabetes Obes Metab       Date:  2020-02-18       Impact factor: 6.577

Review 7.  Potential Beneficial Actions of Fucoidan in Brain and Liver Injury, Disease, and Intoxication-Potential Implication of Sirtuins.

Authors:  Jasmina Dimitrova-Shumkovska; Ljupcho Krstanoski; Leo Veenman
Journal:  Mar Drugs       Date:  2020-05-05       Impact factor: 5.118

Review 8.  Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind.

Authors:  Marco Infante; Martina Leoni; Massimiliano Caprio; Andrea Fabbri
Journal:  World J Diabetes       Date:  2021-07-15

Review 9.  Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions.

Authors:  Nadezda Apostolova; Francesca Iannantuoni; Aleksandra Gruevska; Jordi Muntane; Milagros Rocha; Victor M Victor
Journal:  Redox Biol       Date:  2020-05-25       Impact factor: 11.799

Review 10.  Metformin: A Possible Option in Cancer Chemotherapy.

Authors:  Chidiebere V Ugwueze; Odunze J Ogamba; Ekenechukwu E Young; Belonwu M Onyenekwe; Basil C Ezeokpo
Journal:  Anal Cell Pathol (Amst)       Date:  2020-04-27       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.